Recruiting NCT06527521
Prevalence of Amyloidosis in Trauma Patients
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Traumatologic surgery.
- Who it may be relevant to
- Registry conditions: Amyloidosis. Basic parameters: No limits · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Spain
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Prevalence of Amyloidosis in Trauma Patients Using Red Flags Tool
Overview
This study aims to determine the frequency of amyloidosis among patients undergoing trauma surgery.
Interventions
- Procedure Traumatologic surgery
Patients undergoing trauma surgery
Primary outcome measures
- Amyloidosis [Time frame: One month]
Eligibility criteria
Inclusion criteria
- Men and women included in the waiting list for scheduled trauma surgery with at least one of the following criteria defined as red flags: Over 65 years old; Possible family history of amyloidosis, Cardiac pathology: aortic stenosis, presence of left ventricular hypertrophy defined as interventricular septal thickness > 12mm measured by echocardiography, history of previous brady- or tachyarrhythmias including cardiac conduction blocks, history of syncope or presyncope, pro BNP > 300 in previous blood tests; History of sensory peripheral neuropathy; History of nephropathy without etiological diagnosis; History of liver disease without a clear cause.
- Ability to cooperate in the necessary evaluations.
- Signed informed consent for inclusion in the study, either by the participant or their legal representative.
Exclusion criteria
\- Participants previously diagnosed with amyloidosis cannot be included in the study.
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Cohort
Study locations
Spain · 1 center
- Consorci Sanitari Alt Penedes i Garraf-Hospital Sant Camil — Sant Pere de Ribes
Identifiers
NCT: NCT06527521 · CSAPG-61